Articles

FDA Approves Adakveo to Reduce Vaso-Occlusive Crises in Patients with Sickle-Cell Disease
By Yvette Florio Lane
FDA Approvals, News & Updates, In the News
Web Exclusives
On November 15, 2019, the FDA approved crizanlizumab (Adakveo; Novartis) to reduce the frequency of vaso-occlusive crises (VOCs) in adults and pediatric patients aged ≥16 years with sickle-cell disease.
Read More
Pharmacy’s Emerging Influence and the Roles Pharmacists Play
Pharmacy’s Emerging Influence and the Roles Pharmacists Play
Conference Correspondent
Leaders in oncology pharmacy tackle some of the biggest issues in the field today in a pre-summit professional development session.
Read More
Cancer Centers and the Integrated Health Delivery Systems and the Cancer Care Value Perspectives
Cancer Centers and the Integrated Health Delivery Systems and the Cancer Care Value Perspectives
Conference Correspondent
Stakeholders address the challenge of integrating high-cost therapies into cancer care delivery.
Read More
Insurance Payers and the Cancer Care Value Perspectives
Insurance Payers and the Cancer Care Value Perspectives
Conference Correspondent
Payers identify strategies for promoting value-based, high-quality cancer care.
Read More
Keynotes Highlight a Successful Summit—Stellar Duo Delivers Outstanding Talks
Keynotes Highlight a Successful Summit—Stellar Duo Delivers Outstanding Talks
Conference Correspondent
A pair of distinguished keynote speakers gave attendees a rare behind-the-scenes look at healthcare policy decisions at the highest levels.
Read More
Working with Integrated Health Delivery Systems in Cancer Care Ecosystem
Working with Integrated Health Delivery Systems in Cancer Care Ecosystem
Conference Correspondent
The Summit kicked off with opening remarks and the first of the event’s in-depth pre-summit professional development sessions—designed to take a deep dive into select topics.
Read More

Page 87 of 329

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
Amplity
© Amplity, Inc. All Rights Reserved. Privacy Policy.